Cargando…
Pathogenesis and drug response of iPSC-derived cardiomyocytes from two Brugada syndrome patients with different Na(v)1.5-subunit mutations
Brugada syndrome (BrS) is a complex genetic cardiac ion channel disease that causes a high predisposition to sudden cardiac death. Considering that its heterogeneity in clinical manifestations may result from genetic background, the application of patient-specific induced pluripotent stem cell-deriv...
Autores principales: | Zhu, Yue, Wang, Linlin, Cui, Chang, Qin, Huiyuan, Chen, Hongwu, Chen, Shaojie, Lin, Yongping, Cheng, Hongyi, Jiang, Xiaohong, Chen, Minglong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Department of Journal of Biomedical Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502687/ https://www.ncbi.nlm.nih.gov/pubmed/34628405 http://dx.doi.org/10.7555/JBR.35.20210045 |
Ejemplares similares
-
Inhibition of Wnt/β‐catenin signaling upregulates Na(v)1.5 channels in Brugada syndrome iPSC‐derived cardiomyocytes
por: Lu, Aizhu, et al.
Publicado: (2023) -
iPSC-Cardiomyocyte Models of Brugada Syndrome—Achievements, Challenges and Future Perspectives
por: Nijak, Aleksandra, et al.
Publicado: (2021) -
Patient-specific iPSC-derived cardiomyocytes reveal variable phenotypic severity of Brugada syndrome
por: Sun, Yaxun, et al.
Publicado: (2023) -
Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020) -
Comparing human iPSC-cardiomyocytes versus HEK293T cells unveils disease-causing effects of Brugada mutation A735V of Na(V)1.5 sodium channels
por: de la Roche, Jeanne, et al.
Publicado: (2019)